Entrada Therapeutics Inc
NASDAQ:TRDA

Watchlist Manager
Entrada Therapeutics Inc Logo
Entrada Therapeutics Inc
NASDAQ:TRDA
Watchlist
Price: 10.05 USD -2.24% Market Closed
Market Cap: 384.1m USD

Wall Street
Price Targets

TRDA Price Targets Summary
Entrada Therapeutics Inc

Wall Street analysts forecast TRDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRDA is 16.83 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

Lowest
Price Target
13.13 USD
31% Upside
Average
Price Target
16.83 USD
67% Upside
Highest
Price Target
21 USD
109% Upside
Entrada Therapeutics Inc Competitors:
Price Targets
BVXP
Bioventix PLC
114% Upside
HPHA
Heidelberg Pharma AG
124% Upside
BBIO
BridgeBio Pharma Inc
10% Upside
PRME
Prime Medicine Inc
87% Upside
6628
Transcenta Holding Limited
553% Upside
CYTK
Cytokinetics Inc
35% Upside
086900
Medy Tox Inc
11% Upside
EDIT
Editas Medicine Inc
146% Upside

Revenue
Forecast

Revenue Estimate
Entrada Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Entrada Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Entrada Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRDA's stock price target?
Price Target
16.83 USD

According to Wall Street analysts, the average 1-year price target for TRDA is 16.83 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

Back to Top